Coronary Disease Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
L
Recruiting
  • Coronary Disease
  • +9 more
  • Sirolimus Eluting Balloon
  • Lucerne, Switzerland
    Luzerner Heart Centre
2022-03-31
Mar 31, 2022
N
Completed
  • Coronary Artery Disease
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-04-07
    Apr 7, 2022
    H
    Recruiting
    • Coronary Disease
    • Drug eluting stent
    • Durg coated balloon
    • Zhengzhou, Henan, China
      Fuwai central China cardiovascular Hospital
    2022-03-29
    Mar 29, 2022
    M
    Completed
    • Coronary Stenosis
    • +3 more
    • EluNIR Ridaforolimus Eluting Coronary Stent System
    • Be'er Sheva, Israel
    • +8 more
    2022-04-05
    Apr 5, 2022
    I
    Active, not recruiting
    • Coronary Disease
    • Mobile application
    • Cádiz, Spain
      Hospital Puerta del Mar
    2022-04-05
    Apr 5, 2022
    H
    Recruiting
    • Coronary Artery Disease
    • +9 more
    • immediate stenting group(one-step strategy)
    • deferred stenting group (two-step strategy)
    • Harbin, Heilongjiang, China
      The 2nd Affiliated Hospital of Harbin Medical University
    2022-03-31
    Mar 31, 2022
    H
    Recruiting
    • Coronary Disease
    • remote ischemic preconditioning (RIPC)
    • Zhengzhou, Henan, China
      Fuwai central China cardiovascular Hospital
    2022-03-29
    Mar 29, 2022
    A
    Not yet recruiting
    • Coronary Syndrome
    • +2 more
    • coronary artery bypass grafting surgery
    • (no location specified)
    2022-03-18
    Mar 18, 2022
    N
    Recruiting
    • Coronary Disease
    • The Toshiba Aquilion ONE CT system
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-03-24
    Mar 24, 2022
    U
    Recruiting
    • Acute Coronary Syndrome
    • +3 more
      • Bologna, Emilia Romagna, Italy
        University of Bologna
      2022-03-10
      Mar 10, 2022
      A
      Active, not recruiting
      • Coronary Artery Disease
      • +3 more
      • Absorb BVS
      • XIENCE
      • Birmingham, Alabama
      • +119 more
      2022-03-19
      Mar 19, 2022
      B
      Recruiting
      • Coronary Disease
      • Paclitaxel DCB
      • Beijing, Beijing, China
        Beijing Hospital
      2022-03-21
      Mar 21, 2022
      B
      Completed
      • Coronary Disease
      • Paclitaxel DCB
      • DES
      • Beijing, Beijing, China
        Beijing Hospital
      2022-03-21
      Mar 21, 2022
      U
      Completed
      • Cardiac Output, Low
      • Coronary Disease
      • Liberal dobutamine protocol
      • Restrictive dobutamine protocol
      • Sao Paulo, SP, Brazil
        Heart Institute
      2022-03-14
      Mar 14, 2022
      B
      Active, not recruiting
      • Cardiovascular Diseases
      • +9 more
        • (no location specified)
        2022-03-01
        Mar 1, 2022
        U
        Completed
        • Coronary Disease
        • +6 more
        • Copayment Elimination
        • Personalized Education
        • Calgary, Alberta, Canada
          University of Calgary
        2022-03-02
        Mar 2, 2022
        A
        Completed
        • Coronary Artery Disease
        • +3 more
        • Absorb BVS
        • XIENCE
        • Birmingham, Alabama
        • +191 more
        2022-03-03
        Mar 3, 2022
        C
        Active, not recruiting
        • Coronary Disease
        • Coronary Stenoses
        • quantitative coronary angiography guided coronary intervention with sirolimus-eluting Orsiro/Orsiro mission stent
        • intravascular ultrasound guided coronary intervention with sirolimus-eluting Orsiro/Orsiro mission stent
        • Anam, Korea, Republic of
        • +8 more
        2022-03-01
        Mar 1, 2022
        U
        Completed
        • Heart Failure
        • +2 more
        • Resynchronization using a transeptal approach
        • Resynchronization using a coronary sinus approach
        • Pessac, France
          Cardiologic Hospital Haut l'évêque
        2022-02-08
        Feb 8, 2022
        O
        Completed
        • Hypercholesterolemia
        • Coronary Disease
        • Ezetimibe/Simvastatin 10/20 mg
        • simvastatin 40 mg
        • (no location specified)
        2022-02-07
        Feb 7, 2022
        U
        Not yet recruiting
        • Coronary Disease
        • Mobile application
        • (no location specified)
        2022-02-18
        Feb 18, 2022
        O
        Completed
        • Coronary Disease
        • MK0653, ezetimibe / Duration of Treatment: 27 Weeks
        • +2 more
        • (no location specified)
        2022-02-07
        Feb 7, 2022
        O
        Completed
        • Hypercholesterolemia
        • +2 more
        • MK0653A , ezetimibe (+) simvastatin
        • +2 more
        • (no location specified)
        2022-02-03
        Feb 3, 2022
        O
        Completed
        • Hypercholesterolemia
        • Coronary Disease
        • MK0653, ezetimibe
        • Comparator: ezetimibe, placebo
        • (no location specified)
        2022-02-03
        Feb 3, 2022